Cordis ยท 2 months ago
Analyst II Pricing (REMOTE)
Cordis is a global leader dedicated to transforming cardiovascular care and saving lives. The Analyst II, Pricing will support the Revenue Operations team by maintaining accurate pricing in the JD Edwards system and collaborating with various departments to ensure compliance and efficiency in pricing operations.
Health CareHealth DiagnosticsMedical
Responsibilities
Accurately load, update, and maintain customer-specific pricing, discounts, and contract terms in JD Edwards, ensuring compliance with approved pricing guidelines
Execute daily and monthly pricing processes, including updates, validations, and system checks to ensure data accuracy and timely application of changes
Investigate and resolve pricing discrepancies or data issues, escalating complex cases to senior teammates or system support teams as needed
Collaborate with the Strategic Pricing Team for guidance on pricing structure, independent accounts, GPO/IDN, Government, and OUS distributor pricing
Prepare and deliver recurring reports and analyses (e.g., expiration reports, discrepancy credits, bulk purchase requests) with attention to accuracy and timeliness
Support pricing process documentation, SOP updates, and compliance reviews
Provide feedback on recurring issues or process gaps, contributing ideas for continuous improvement and efficiency
Assist in testing and validating new system functionalities or pricing technologies under guidance from senior team members
Maintain a customer-service mindset, ensuring internal stakeholders receive prompt and accurate pricing support
Qualification
Required
3+ years of experience in pricing, systems software, or an operations related field, preferably within a medical device or healthcare industry
Bachelor's degree in business administration, IT, or related field. Relevant JDE certification is a plus. Combined education and/or experience will be considered
Company
Cordis
Cordis Corporation, a Johnson & Johnson company, has pioneered less invasive treatments for vascular disease.
Funding
Current Stage
Late StageTotal Funding
unknown2021-03-12Acquired
Recent News
2025-11-11
TeamBest Global Companies
2025-11-07
News-Medical.Net
2025-11-01
Company data provided by crunchbase